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Abstract 
UWM-Adverse Drug Events Corpus (UWM-ADEC) is an annotated corpus that has been developed from consumer 
drug review posts in social media. In this corpus, we identified four types of Adverse Drug Reactions (ADRs) 
including physiological, psychological, cognitive, and functional problems. Additionally, we mapped the ADRs to 
corresponding concepts in Unified medical language Systems (UMLS). The quality of the corpus was measured 
using well-defined guidelines, double coding, high inter-annotator agreement, and final reviews by pharmacists and 
clinical terminologists. This corpus is a valuable source for research in the area of text mining and machine 
learning for ADRs identifications from consumer health posts, specifically for psychiatric medications.  
Introduction 
Clinical trials and post-marketing surveillance systems established by regulatory agencies, such as the Adverse 
Event Reporting System (AERS) of the Food and Drug Administration (FDA), are not sensitive enough to detect the 
potential risks of drugs before marketing and moreover the occurrence of potential adverse drug reactions 
(ADRs) after wider use in patients. It is estimated that current surveillance systems capture less than 10% of 
the ADRs occurrence, due to voluntary nature of data collection and perhaps, patients’ negative perceptions of the 
reporting systems (Yang, Yang, Jiang, & Zhang, 2012). These limitations have led to major concerns in public 
health because of recent reports thousands of incidents of hospitalizations and deaths (Karimi, Metke-Jimenez, 
Kemp, & Wang, 2015). 
Recent studies have shown the potential significance of using consumer health posts from social media as a 
supplementary health data source to improve identifying ADRs. Therefore, regulatory agencies such as the FDA’s 
Sentinel Initiative, have considered this source for actively monitoring for ADRs. However, there are challenges to 
automatic extraction of ADRs from social media, such as colloquial expressions of ADRs and deviation 
of sentence/phrase structure from formal sentence/phrase structure. These deviations can significantly reduce recall 
and precision of the automatic extraction of ADRs from consumer health posts.  
A human annotated corpus can significantly improve performance of computerized systems aimed to identify health 
entities from unstructured consumer health posts. Development of such corpus is a very costly process. In line with 
the needs of improving performance of text mining algorithms in the area of pharmacovigilance, we developed a 
corpus of ADRs from a healthcare forum called “askapatient.com”, which collects drug reviews from patients. We 
extracted ADRs from the review posts in this forum and mapped them to their corresponding terms in Unified 
medical language Systems (UMLS). To our knowledge, this corpus is the first corpus that covers a wide-range of 
ADRs associated with psychiatric medications, including physiological, psychological, cognitive, and functional 
adverse reactions.  
Background 
The lexicon-based approach for name entity recognition in the area of pharmacovigilance currently dominates other 
methods of health entity extraction in consumer health posts. The lexicons have been mostly developed by 
combining standard medical vocabularies including COSTART (that was developed by the FDA for coding post-
marketing ADR reports and was later replaced by MedDRA), the FDA Adverse Event Reporting System (FAERS), 
MedEffect (Canadian Adverse Reaction and Medical Device Problem Reporting database), SIDER (which has been 
developed based on resources published by public sources, mainly the FDA such as structured product labeling 
(SPL)), the Drug Bank Database, and  the European agency for the Evaluation of Medical Product (EMEA). The 
lexicons were mainly built on clinical trial findings and clinicians’ reports, which often have low coverage of 
colloquial expressions available in consumer health posts. To address this problem, pharmacovigilance studies have 
used a few approaches mostly focused on augmentation of the standard medical lexicons by embedding Consumer 
Health Vocabularies (CHV). CHV was developed mainly with the purpose of covering colloquial expression of 
health professional vocabularies (Zeng & Tse, 2006). Here, we explain three studies which have adopted lexicon-
based approaches for identifying ADRs from consumer health posts.  
  
Leaman et al. (2010) constructed a lexicon of SIDER, MedEffect, and COSTART, which was augmented with CHV 
and a small set of ADR colloquial expression to identify adverse drug reactions in consumer drug reviews in the 
“Daily Strength” forum. This study had 78.3% precision and 69.9% recall. Benton et al. (2011) complied a lexicon of 
dietary supplements, pharmaceutical terms mentioned in the Cerner Multum’s Drug Lexicon, list of signs and 
symptoms in the Medicinenet database, FAERS, and CHV to identify ADRs of hormonal drugs used for breast cancer 
treatment in breast cancer healthcare forums. The reported precision was 77% and recall 35.1% . Liu and Chen (2013) 
constructed AZD Drug Minor on UMLS, which provided 56.5% recall and 82% precision for ADRs identification in a 
healthcare forum.  
Pharmacovigilance studies that focused on identifying ADRs from consumer healthcare forums mostly attributed 
systems errors to misspelling, colloquial expression of ADRs, use of non-standard terms, and high variability of 
semantic representations of a specific ADR in health posts. In addition, augmentation of the standard lexicons with 
CHV did not improve the system’s recall significantly, indicating that the CHV is not rich in colloquial expressions 
of ADRs. Therefore, there is a need for an annotated corpus that not only clarifies the text segments of health posts 
for the presence of specific information, such as ADRs, but also fills the gap between patient and clinician 
terminologies by mapping colloquial expressions to standard medical terminologies.   
In line with this need,  Ginn et al. (2014) developed an open source Twitter corpus, which was built on 10,822 
instances of randomly selected tweets (each instance of tweet is a maximum of 140 characters) for drugs prescribed 
for chronic illness. The tweets were double coded by two annotators for presence of ADRs, spans of ADRs, drug 
indications, and beneficial effects. For this data set, the Inter Annotator Agreement (IAA) calculated using Cohen’s 
Kappa was 71%. The authors normalized the identified medical terms by mapping layperson expressions to the 
UMLS standard terminology. Karimi et al. (2015) developed CADEC corpus, which was built on drug review posts 
in online message board “askapatients.com”. The corpus consists of 1,231 comments for two sets of drugs, 
Diclofenac and Lipitor. The drug reviews were annotated for span of ADRs (6,318) where mapped to both 
SNOMED-CT and MEDRA terminologies. The pair-wise agreement between annotators was 60.4 % , when span 
and annotation settings were both strict. 
The UWM-ADEC corpus is specifically developed for identifying ADRs associated with psychiatric medications. 
Although these medications have shown substantial evidence of effectiveness in treatment of mental illness such as 
depression and anxiety, they are associated with significant numbers of physiological, psychological, and cognitive 
ADRs unique to these types of medications. We built UWM-ADEC on drug reviews from “askapatient.com” for 
two classes of psychiatric medications including SSRI (Selective Serotonin Reuptake Inhibitor) and SNRI 
(Serotonin–norepinephrine reuptake inhibitor). In addition, we identified functional problems associated with drugs’ 
adverse effects, such as limitations in daily functioning and social activities from the drug reviews. Identifying drug-
induced functional problems was not previously identified in CADEC and the Twitter corpus. Functional problems 
can result in patient non-adherence behavior, and therefore may lead to an increased risk of illness relapse, 
emergency room visits and hospitalizations.  
UWM-ADEC can be used for text mining systems and machine learning systems, specifically for psychiatric 
medication pharmocovigilance  and hypothesis testing related to the impact of the ADRs on attitude, 
discontinuation, and other medical entities.  
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Methodology 
Dataset Information 
We examined data from an Online Message Board (OMB) “askapatient.com” that compiles uncensored user 
comments on the effects of taking different types of medication from people with a range of clinical diagnoses. In 
this OMB, patients can record their experience with a medication by filling out a form for a medication brand name. 
This form is composed of eight fields including rating, reason for prescription, side-effects, comments, gender, age, 
duration/dosage, and date of posting the review. Patients can rate their satisfaction with drugs ranging from 1 to 5, 
where 1 presents the least satisfaction and 5 presents the highest satisfaction. Patients are instructed to report drug 
ADRs in the side-effect field and the details of their experience in the comment field. However, patients were noted 
to report various aspects of their experiences, such as drug effectiveness or perceived distress due to ADRs, in both 
fields. Table 1 shows an example of posts for Cymbalta in “askapatient.com”. 
Table 1. An example of a post for Cymbalta in “askpatient.com”. 
Drug Source 
We used drug review posts in “askapatients.com” to collect information for four psychiatric medications: Sertraline (brand 
name: Zoloft) and Escitalopram (brand name: Lexapro) from Selective Serotonin Reuptake Inhibitor (SSRI) Class and 
venlafaxine (brand name: Effexor XR) and duloxetine (brand name: Cymbalta) from Serotonin Norepinephrine Reuptake 
Inhibitor (SNRI) Class. These four drugs have been primarily prescribed for depression and mood disorders. According to a 
dataset from Symphony Health Solutions, these medications had the highest prescription rates in 2012. 
Data Collection  
Because this healthcare forum does not have application program interface (API), we designed a web-crawler to collect 
information from the OMB. Since there is an option for filtering drug reviews for a specific drug, we could collect the 
data without requiring further effort. All the data in askapatient.com is anonymous and publicly available. Therefore, 
we did not seek any IRB approval for the data collection phase. 
Dataset Statistics 
We randomly selected 892 posts from a healthcare forum 
called “askapatient.com”. Table 2 shows demographic 
information of the whole sample. The gender proportion in the 
sample for female is significantly higher than male for both 
classes of drugs. Age range of the reviewer is 14-83 years old 
with the average of 37, and median of 35; implying that 
patients less than 40 are more likely to report their experience 
with drugs. Duration of drug usage ranged from 1 day to 20 
years with an average of 18 months and median of 5 months, 
indicating that the duration of usage is highly skewed due to 
the effect of outliers. Posting reviews as soon as 1 day of 
treatment may indicate patients’ high concern for potential 
ADRs. 
Annotation 
We created the corpus in two main phases: (1) ADR 
identification and (2) terminology association, also known as 
normalization, in which we linked the identified entities to 
Rating Reason Side-effect Comment Gender Age Duration Date 
3 fibromyalg
ia/depressi
on 
Nausea, diarrhea, 
upset stomach, dry 
mouth, sleepiness 
I have only been on 30mg for 4 days 
and have the extreme runs.  Upset 
stomach and no appetite.  Pain in 
minimal though and I feel less 
anxious and depressed. 
F 38 4 days 2009-10-05 
Table 2. Corpus statistics 
Dataset statistics Dataset 
Sample Size 892 
No. of reviews with text  887 
Time span Feb 2001  
Sep 2016 
Rating 3.16 
Gender F 669 (76%) 
M 212 (24%) 
Missing value (11) 
Age Avg. 37 
Med. 35 
Missing values (12) 
Age range 14-83 
Missing values (3)  
Duration of usage Avg. 18 months 
Med. 5 month 
Duration of usage (range) 1 day - 20 years 
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controlled vocabularies. In the next sections, we explain the annotation guidelines and the annotation process.  
Developing Guidelines for ADRs Identification 
Guidelines for ADRs identification includes the ADR definitions and rules for proper identification of entities. Table 3 
includes the entity definitions and the associated rules for identification with examples. The identification rules are 
related to patient certainty in linking ADRs with the drug, identifying patient subjective complaints and functional 
problems as ADRs, as well as excluding unnecessary context such as “similes” and “metaphors” from ADRs. 
Identifying patient subjective complaints are important because they may reflect subtle physiological, psychological, or 
cognitive ADRs associated with drugs. For example, “felt like I couldn't stop moving” reflects patient restlessness, 
which is a sign of akathisia. Identifying functional problems in drug review posts is also significant, not only for 
understanding how ADRs influence the normal daily activities of patients and their interpersonal relationships, but also 
for estimating the indirect cost associated with the ADRs. Collecting this information also enhances clinicians' abilities 
to predict the impact of ADRs on patient functionality, such as limitations of daily activities, social participation, and 
work performance. We further categorized identified ADRs as physiological (Phys), Psychological (Psycho), Cognitive 
(Cogn), and functional problem (FP).  	
Table 3. Guidelines for ADRs identification with examples 
   
Annotation Process  
Four annotators participated in the process of identification and extraction of the three entities explained in Table 3. 
In the second step, the documents were divided into three sets and each set was reviewed by an annotator for entity 
identification. In order to calculate inter-annotator agreement, the entire dataset was reviewed by the fourth 
annotator. We did not extract general mentions of entities, such as “side-effects” in the sentences. For example, in 
these sentences, “I really suffered from side-effects,” side effects and was not extracted. 
Entity Definitions Example Rules for identification Example 
ADRs Any sign or 
symptom that 
patient 
explicitly 
associated it 
with drug 
consumption, 
except the phase 
of dosage 
reduction and 
discontinuation. 
 
 
 
My doctor 
increased my dose 
and I felt severe 
dizziness (ADR).  
 
1. Certainty: If patient is not confident 
about the association between ADRs 
and drug, the ADR was not extracted. 
2. Subjective complaints: If ADR is 
expressed as subjective complaint, it 
should be extracted with the entire 
necessary context.  
3. Functional problems: if patient 
mentions their experiences with drugs 
as functional problems, such as 
problem with daily functioning and 
social activities, it should be extracted 
and labeled as an ADR. 
4. Excluding simile and metaphor: If  
patient used a simile or metaphor to 
provide information about his/her 
feelings towards ADRs, that simile or 
metaphor should not be extracted. 
5. Duplicates: Duplicate ADRs in a 
sentence should be independently 
extracted, that is, all the occurrences 
of the entities are identified. 
6. Qualifiers: If an ADR were associated 
with qualifiers presenting severity or 
persistency of it, it needs to be 
identified.  
1. It caused hair loss and 
stomach bloating (ADR), 
however I am not sure that 
hair loss (not ADR) is 
because of the drug.  
2. “It certainly erased the 
anxiety, but I hardly feel 
human anymore (ADR). 
3. I would just stay around 
and do nothing all day 
(ADR). 
4. Very hard to take a deep 
breath (ADR) like 
someone is squeezing my 
lungs. (Smile –non 
necessary) 
5. The anxiety (ADR) was 
debilitating. I also had 
severe headache (ADR), 
but the anxiety (ADR) was 
worse. 
6. Anxiety is now though the 
roof (severity) 
• Constant (persistency) 
bad (severity) 
headaches. 
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Calculating Inter-Annotator Agreement  
To calculate inter-annotator agreement, we used pair-wise agreement between the annotators using the following 
formula (Metke-Jimenez & Karimi, 2015):  𝐴𝑔𝑟𝑒𝑒𝑚𝑒𝑛𝑡 𝐴! ,𝐴! =  𝑚𝑎𝑡𝑐ℎ (𝐴!, 𝐴! ,𝛼,𝛽)𝑚𝑎𝑥 (𝑛!!  , 𝑛!! )  
 
Where Ai represents the set of data annotated by annotator i; Aj  represents the set of data annotated by annotator j; nAi is 
the size of identified entities in Ai and nAj is the size of identified entities in Aj; Max (nAi, nAj) is the maximum number of 
identified entities; 𝛼 parameter presents span strictness of identified entities and 𝛽 parameter represents tag strictness of 
identified entities. The computed pairwise agreement for strict match for ADRs identification was 0.86. 
Terminology Association 
While sentence classification and entity identification in drug review posts have significant implications for 
automatic systems that focus on information retrieval, translating these entities to the language of health 
professionals fills the gap between layperson and professional expressions of medical entities, such as ADRs. This 
translation may benefit the generation and testing of medical hypotheses by providing unambiguous and standard 
information for statistical data collection and analysis. 
This translation process (terminology mapping) typically involves identifying terms used by healthcare consumers 
and mapping them to their equivalent concepts available in medical standard vocabularies. This process is also 
referred to as normalization in other research (Karimi et al., 2015). To normalize the entities in our corpus, we 
mapped the identified entities to their corresponding concepts in Unified Medical Language System (UMLS). The 
UMLS Metathesaurus is a compendium of many standard medical vocabularies that provides a mapping structure 
among vocabularies, allowing one to translate among various terminology systems. The Metathesaurus is organized 
by concepts. Each concept is assigned one Concept Unique Identifier (CUI) and one or more semantic type 
(categories). Mapping ADRs to UMLS, in addition to normalization benefit, often reveals a list of consumer health 
vocabularies that has not been covered by current medical terminologies. 
Guidelines for Terminology Association 
Due to the different ways in which symptoms, feelings, concerns etc. are described by lay persons and medical 
professionals, simple matching of words will sometimes fail to capture the synonymy in meaning. For example, the 
consumer term “feeling sick in my stomach” is equivalent to the medical term “nausea” but no words are shared. 
Therefore, proper mapping of consumer terms to the concepts in the UMLS must take into account both lexical and 
semantic matching. Since this process sometimes involves subjective judgment, to ensure consistency in mapping, 
we have drawn up mapping guidelines, which were iteratively updated. These guidelines were based on insights we 
gained by reviewing publications including clinical trial studies targeting ADRs of the drugs specified in this study 
and qualitative studies investigating the themes of patient experiences with the drugs. In these publications, ADRs 
are often grouped into three broad areas: physiological, psychological, and cognitive, an approach which we have 
also adopted in our study.  
In some cases, the symptom mentioned by the patient is more fine-grained than the meaning of a UMLS concept, whose 
meaning is more general and broader in scope. In such cases, we label the map as a “specific-to-general” map. One 
example is the UMLS concept “executive dysfunction”. According to our research, executive dysfunction as a cognitive 
ADR is associated with inability to initiate and follow processes of completing a task, such as problems with initiating a 
task, problems with organizing a task, or problems with switching between tasks. So for a patient complaint of “cannot 
follow through on simple tasks”, we map it to “executive dysfunction” as a more general concept. 
Mapping Process  
Three annotators with diverse backgrounds (pharmacist, physician, and health scientist) mapped the ADRs to proper 
UMLS concepts based on the guidelines of mapping that we developed for this study. Annotators used the UMLS 
Terminology Services, UTS browser (2017) for finding proper UMLS and SNOMD-CT concepts. Example of 
mapping the concepts to UMLS is shown in Table 4. 
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Table 4. Examples of mapping ADRs to UMLS Concepts 
Drug_ID Sen_ID Original Term UMLS (1) 
cymbalta.124 1 Felt sick C0857027 / Feeling Sick /Sign or Symptom 
lexapro.12 3 “Zombie” like C0857486/ Felt like a zombie/ Finding 
cymbalta.12 2 Constipation C0009806/ Constipation/ Sign or Symptom  
cymbalta.131 1 Excessive sleepiness C0013144/ Drowsiness/ Finding 
Effexor.78 1 Minor muscle spasms C0037763 / Spasm/ Sign or Symptom 
effexor.97 2 Sweating like crazy all the 
time 
C0700590 / Increased sweating / Sign or 
Symptom 
effexor.111 7 Brain zap No concept 
 
Corpus Statistics 
Table 5 lists frequency of identified ADRs for the corpus, as well as type of ADRs separately. Overall, we identified 
4776 ADRs where 31% were duplicates, with the lowest number of duplicates for functional problems, followed by 
psychological problems. The findings indicate the level of subjectivity of functional and psychological ADRs that 
leads to creating different phrases by patients to describe their feelings and problems. Functional problems only 
made up 2% of the total ADRs, indicating that patients prefer to discuss physical and psychological effects of the 
drugs in review posts rather than their impacts on their quality of life. For the purpose of designing more effective 
medication adherence interventions, it would be useful if healthcare forums also asked patients to report the impact 
of drugs on their daily functioning and social activities.  
Table 5. Frequency of identified ADRs for the total corpus 
 Total Physiological Psychological Cognitive Functional 
 ADRs Unique All  Unique All Unique All Unique All Unique 
ADRs 
in 
Corpus 
4776 
 
69% 
(All) 
3285 
3522 64% 
(All) 
2274 
900 81% 
(All) 
(716) 
272 80% (All) 
(217) 
82 95% (All) 
(78) 
 
Statistics for annotation from the normalization stage were also shown in Table 6. The final normalization set 
contains 695 concepts from UMLS concepts, from which 61% belong to the physiological category and only 5% of 
the concepts are related to the functional category. We also report the two most frequently mapped concepts with 
their frequencies across the corpus for each category of ADRs.  
Table 6. Statistics for annotation from normalization stage 
 Total Physiological Psychological Cognitive Functional 
No. Unique 
concepts  
695 425 (61% total) 196 (28% total) 42 (6% total) 31 (5%) 
No. Unique 
concepts  
695 425 (61% total) 196 (28% total) 42 (6% total) 31 (5%) 
1st most freq. 
concept  
Sleeplessness 
(171) 
Sleeplessness 
(171) 
Anxiety (94) Foggy feeling 
in head (47) 
Difficulty in daily 
functioning (10) 
2st most freq. 
concept 
Nausea (169) Nausea (169) Detailed recall 
of dream (62) 
Unable to 
concentrate 
(30) 
Emergency room 
admission (9) 
Normalization Challenge 
While normalization of consumer health posts has significant implications for understanding pharmacological 
aspects of medications, it is a subjective process. We attempted to address this by developing guidelines that 
include underlying concepts for both patient and professional expressions of entities. But, some expressions strongly 
related to the life context of patients. For example, we did not map “hardly feel human anymore” to any concepts 
due to uncertainty of the underlying concepts associated with it. It is not clear what the patient meant with this 
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expression: is it about the patient feeling emotionally detached, having a problem in performing daily activities, or is 
it about feeling detached from his mind and his body (de-realization)?   
There were also some cases that, while the expression of an ADR is clear and can be translated to an equivalent 
medical concept, there are no UMLS concepts available for it. For example, brain zap, which is known as 
the professional term “brain shivers”, does not have any concept in UMLS. 
Limitations 
Sample size 
The size of sample is limited to 892 posts for four psychiatric medications. While this sample size is a good 
representative of the four most common psychiatric medications, it may not be a good representative of other 
consumer posts in this forum or other healthcare forums. It is also possible that a specific group of patients tend to 
report their experiences with drugs in this forum leading to reporting bias.  
Limitation for coverage of drug types 
Our corpus covers sentence labeling and entities identifications for two classes of psychiatric medications, SSRI and 
SNRI. While limiting the dataset to a specific set of drugs enabled us to have a better understanding of conceptual 
models associated with layperson and professional expressions of medical entities, it may not include rare ADRs 
related to other classes of psychiatric medications and medications for other diseases or disorders.  
Lack of information on drug-drug interactions, drug-herb interaction, and drug overdose 
The focus of patients in review posts is mostly on the selected drug. Hence, it is not clear, whether the reported 
adverse effects are merely caused by the drug or it is the result of interaction of the drug with other potential drugs 
or herbal treatment that administered by patients.  Moreover, some of the ADRs for psychiatric medications, such 
suicidal ideation or emergency visits can happen because of patient’s overdose, this information is not available in 
the review posts because of the nature of these reports.  
Uncertainty of data in social media 
Although patient self-reported experiences is a reliable source for evaluating pharmacological effects of 
medications, there is still the risk of inaccurate and false information. In addition, we only identified and extracted 
ADRs that patients directly associated with their medications, however, there is the possibility that patients 
misinterpreted the symptoms of their psychiatric condition as an ADR of their psychiatric medication.  
Possibility of human errors in data analysis 
Although the entire data set is double coded, there is still the possibility that annotators did not interpret a sentence 
correctly and therefore assign a wrong label to it. In addition, the span of the identified entities may include less or 
more information than necessary. These problems affect the performance of any machine learning system trained on 
this corpus to identify drug effectiveness, ADRs, and drug indications in consumer health posts.  
Conclusions and Future Work  
We have created a corpus of ADRs with the purpose of improving recall and precision of automatic systems 
designed for identifying ADRs from social media. The source of this corpus is patient reviews of psychiatric drugs 
in a medical forum called askpatient.com. Sentences in review posts were annotated for the presence of ADRs and 
span of ADRs. This corpus can benefit researchers in several areas including 1) developing and evaluating systems 
that automatically identify ADRs from consumer health posts, 2) developing systems that automatically map free 
text to UMLS, 3) Creating a structured vocabulary of layperson expressions of adverse effects and indications which 
can be used in electric health records (EHR) for facilitating seamless information between patients and 
clinicians. This can be achieved by mapping information in personal health records (PHR) to EHR systems.  
We are in the process of annotating withdrawal symptoms, drug indications, and effectiveness from the consumer 
health reports. We are also mapping the entities to corresponding terms in SNOMED-CT terminology.   
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